Elisabeth Traxler-Zwickl

Krems An Der Donau, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity.

Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity.

Journal: Blood cancer journal

Published: April 13, 2024

Evaluation of Ki-67 as a Prognostic Marker in Diffuse Large B-Cell Lymphoma-A Single-Center Retrospective Cohort Study.

Evaluation of Ki-67 as a Prognostic Marker in Diffuse Large B-Cell Lymphoma-A Single-Center Retrospective Cohort Study.

Journal: Current oncology (Toronto, Ont.)

Published: October 17, 2021

Effect of cachexia on bone turnover in cancer patients: a case-control study.

Effect of cachexia on bone turnover in cancer patients: a case-control study.

Journal: BMC cancer

Published: April 20, 2021

Evaluation of personalized cancer therapies based on comprehensive genomic profiling in a middle-sized oncologic center in Austria, the University Clinic Krems.

Evaluation of personalized cancer therapies based on comprehensive genomic profiling in a middle-sized oncologic center in Austria, the University Clinic Krems.

Journal: Translational oncology

Published: October 24, 2020

Retrospective analysis of the prevalence of specialised palliative care services for patients with metastatic breast cancer.

Retrospective analysis of the prevalence of specialised palliative care services for patients with metastatic breast cancer.

Journal: ESMO open

Published: July 10, 2020

Reduced LDL-Cholesterol and Reduced Total Cholesterol as Potential Indicators of Early Cancer in Male Treatment-Naïve Cancer Patients With Pre-cachexia and Cachexia.

Reduced LDL-Cholesterol and Reduced Total Cholesterol as Potential Indicators of Early Cancer in Male Treatment-Naïve Cancer Patients With Pre-cachexia and Cachexia.

Journal: Frontiers in oncology

Published: January 29, 2020

Is Neuronal Histamine Signaling Involved in Cancer Cachexia? Implications and Perspectives.

Is Neuronal Histamine Signaling Involved in Cancer Cachexia? Implications and Perspectives.

Journal: Frontiers in oncology

Published: July 09, 2019

Tolerability of obinutuzumab therapy in patients with rituximab-relapsed/refractory B-cell malignancies - a retrospective single center cohort study.

Tolerability of obinutuzumab therapy in patients with rituximab-relapsed/refractory B-cell malignancies - a retrospective single center cohort study.

Journal: Oncotarget

Published: May 13, 2018

Evaluation of vascular events in patients with myeloproliferative syndromes and mutations of either the januskinase-2 or calreticulin gene at the university hospital Krems from 2008 to 2015.

Evaluation of vascular events in patients with myeloproliferative syndromes and mutations of either the januskinase-2 or calreticulin gene at the university hospital Krems from 2008 to 2015.

Journal: Oncotarget

Published: August 12, 2017

A single-center retrospective analysis of first-line therapy of multiple myeloma with bendamustine-bortezomib-dexamethasone.

A single-center retrospective analysis of first-line therapy of multiple myeloma with bendamustine-bortezomib-dexamethasone.

Journal: Leukemia & lymphoma

Published: February 23, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026